Samjin Pharm to undertake joint ADC R&D with Novelty Nobility

SamjinPharmaceutical announced Wednesday that it has signed a joint research agreement with Novelty Nobility Inc., a company specializing in antibod...
SamjinPharmaceutical announced Wednesday that it has signed a joint research agreement with Novelty Nobility Inc., a company specializing in antibod...
South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...
Netflix's original South Korean drama series Hellbound topped the platform’s global chart within a day of its Nov. 19 release, much faster tha...